CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Eisai Company Limited - ADR Company Snapshot
Eisai Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other pharmaceutical manufacturers in North America: Daiichi Sankyo Company Limited (2020 sales of $9.06 billion of which 93% was Prescription drugs), Prestige Consumer Healthcare Inc ($963.01 million of which 89% was North Ameriican OTC Healthcare), and Canopy Growth Corp which is based in CANADA (398.77 million Canadian Dollars [US$291.93 million] of which 52% was Recreational cannabis revenue).

Sales Analysis. Eisai Company Limited reported sales of $6.42 billion for the fiscal year ending March of 2020. This represents an increase of 10.9% versus 2019, when the company's sales were $5.79 billion. This was the fourth straight year of sales growth at Eisai Company Limited. Sales of Other Business saw an increase that was more than double the company's growth rate: sales were up 53.3% in 2020, from $712.60 million to $1.09 billion.
   
   
 
  Stock Performance Chart for Eisai Company Limited - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (6/26/2020): 81.50
(Figures in U.S. Dollars)
1 Week 2.7%   13 Weeks 4.5%  
4 Weeks 16.5%   52 Weeks 42.4%  
 
Eisai Company Limited - ADR Key Data:
  Ticker: ESALY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,420,581,830
(Year Ending Jan 2021).
Employees: 10,998
  Currency: U.S. Dollars Market Cap: 23,363,096,848
  Fiscal Yr Ends: March Shares Outstanding: 286,663,765
  Share Type: Common Closely Held Shares: 12,281,067
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.